GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phibro Animal Health Corp (FRA:PB8) » Definitions » Price-to-Operating-Cash-Flow

Phibro Animal Health (FRA:PB8) Price-to-Operating-Cash-Flow : 9.34 (As of May. 26, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Phibro Animal Health Price-to-Operating-Cash-Flow?

As of today (2024-05-26), Phibro Animal Health's share price is €16.90. Phibro Animal Health's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €1.81. Hence, Phibro Animal Health's Price-to-Operating-Cash-Flow Ratio for today is 9.34.

The historical rank and industry rank for Phibro Animal Health's Price-to-Operating-Cash-Flow or its related term are showing as below:

FRA:PB8' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.8   Med: 21.58   Max: 273.61
Current: 9.46

During the past 13 years, Phibro Animal Health's highest Price-to-Operating-Cash-Flow Ratio was 273.61. The lowest was 5.80. And the median was 21.58.

FRA:PB8's Price-to-Operating-Cash-Flow is ranked better than
74.37% of 679 companies
in the Drug Manufacturers industry
Industry Median: 16.89 vs FRA:PB8: 9.46

Phibro Animal Health's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €0.26. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €1.81.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -39.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -24.20% per year.

During the past 13 years, Phibro Animal Health's highest 3-Year average Operating Cash Flow per Share Growth Rate was 170.60% per year. The lowest was -39.20% per year. And the median was 0.20% per year.


Phibro Animal Health Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Phibro Animal Health's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phibro Animal Health Price-to-Operating-Cash-Flow Chart

Phibro Animal Health Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.29 17.93 24.21 24.49 41.64

Phibro Animal Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 41.64 12.85 6.31 6.59

Competitive Comparison of Phibro Animal Health's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phibro Animal Health's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Phibro Animal Health's Price-to-Operating-Cash-Flow falls into.



Phibro Animal Health Price-to-Operating-Cash-Flow Calculation

Phibro Animal Health's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=16.90/1.809
=9.34

Phibro Animal Health's Share Price of today is €16.90.
Phibro Animal Health's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.81.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Phibro Animal Health Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Phibro Animal Health's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Phibro Animal Health (FRA:PB8) Business Description

Traded in Other Exchanges
Address
300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Phibro Animal Health (FRA:PB8) Headlines

No Headlines